AU2003283326A1 - Method for identifying compounds which inhibit mechanotransduction in neurons - Google Patents

Method for identifying compounds which inhibit mechanotransduction in neurons

Info

Publication number: AU2003283326A1
Authority: AU; Australia
Prior art keywords: mechanotransduction; neurons; inhibit; identifying compounds; identifying
Prior art date: 2002-10-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003283326A

Other languages

English (en)

Other versions

AU2003283326A8 (en

Inventor

Andreas Eilers

Paul Heppenstall

Gary Lewin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft

Original Assignee

Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-30

Filing date

2003-10-30

Publication date

2004-05-25

2003-10-30 Application filed by Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft

2004-05-25 Publication of AU2003283326A8 publication Critical patent/AU2003283326A8/xx

2004-05-25 Publication of AU2003283326A1 publication Critical patent/AU2003283326A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Pathology (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)

AU2003283326A 2002-10-30 2003-10-30 Method for identifying compounds which inhibit mechanotransduction in neurons Abandoned AU2003283326A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US42209802P	2002-10-30	2002-10-30
EP02024474.5		2002-10-30
US60/422,098		2002-10-30
EP02024474		2002-10-30
PCT/EP2003/012084 WO2004040299A2 (fr)	2002-10-30	2003-10-30	Technique d'identification de composes inhibiteurs de la transduction mecanique dans les neurones

Publications (2)

Publication Number	Publication Date
AU2003283326A8 AU2003283326A8 (en)	2004-05-25
AU2003283326A1 true AU2003283326A1 (en)	2004-05-25

Family

ID=56290498

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003283326A Abandoned AU2003283326A1 (en)	2002-10-30	2003-10-30	Method for identifying compounds which inhibit mechanotransduction in neurons

Country Status (3)

Country	Link
EP (1)	EP1556693A2 (fr)
AU (1)	AU2003283326A1 (fr)
WO (1)	WO2004040299A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19850015A1 (de) *	1998-10-30	2000-05-04	Max Delbrueck Centrum	Proteine der Stomatinfamilie und ihre Verwendung als Zielproteine für die Schm erztherapie
WO2003060093A2 (fr) *	2002-01-10	2003-07-24	The Trustees Of Columbia University In The City Of New York	Methodes et compositions de propagation de vecteurs contenant de l'adnc toxique et systemes d'analyse de canal ionique

2003
- 2003-10-30 WO PCT/EP2003/012084 patent/WO2004040299A2/fr not_active Ceased
- 2003-10-30 AU AU2003283326A patent/AU2003283326A1/en not_active Abandoned
- 2003-10-30 EP EP03775263A patent/EP1556693A2/fr not_active Withdrawn

Also Published As

Publication number	Publication date
WO2004040299A2 (fr)	2004-05-13
WO2004040299A3 (fr)	2004-07-15
AU2003283326A8 (en)	2004-05-25
EP1556693A2 (fr)	2005-07-27

Publication	Publication Date	Title
AU2003247355A1 (en)	2003-11-10	Process for identifying and treating specified cell types
AU2003272713A1 (en)	2004-04-19	A method for treating severe tinnitus
AU2003245304A1 (en)	2003-12-22	Method for private personal identification number management
AU2002952193A0 (en)	2002-11-07	A method for providing online insurance
AU2003304722A1 (en)	2006-09-18	Method for treating waste-activated sludge using elecroporation
AU2003300530A1 (en)	2004-07-14	Dhodh-inhibitors and method for their identification
AU2003240934A1 (en)	2003-12-19	Method for determining oligonucleotide concentration
AU2003218361A1 (en)	2003-10-27	Method for treating hepatic encephalopathies
GB0301972D0 (en)	2003-02-26	Method for identifying novel treatments
AU2003256995A1 (en)	2004-02-16	Method for identifying cancer risk
AU2003901196A0 (en)	2003-04-03	Analysis method
AU2003902613A0 (en)	2003-06-12	Self-surveying method
WO2004003803A8 (fr)	2004-04-15	Methode de pari
AU2003261957A1 (en)	2004-04-23	Method for separating substances
EP1603386B8 (fr)	2007-05-30	Procede d'aquaculture
AU2003274248A1 (en)	2004-03-03	Method for communicating structured information
AU2003264095A1 (en)	2004-04-30	Method for path-seacher scheduling
AU2002243021A1 (en)	2003-10-13	Method for duplicating shape
WO2004071432A3 (fr)	2005-03-10	Méthode de traitement de l'hypothyroïdie
AU2003233330A1 (en)	2003-12-02	Method for quantifying molecules
AU2003253813A1 (en)	2004-01-23	Method for colpoplasty
AU2003283326A1 (en)	2004-05-25	Method for identifying compounds which inhibit mechanotransduction in neurons
AU2003206331A1 (en)	2003-09-02	Methods for separating oligonucleotides
AU2003243649A1 (en)	2003-12-31	Methods for identifying compounds for treating disease states
AU2003229549A1 (en)	2003-09-09	Improved method for allele-specific pcr

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase